Common Bile Duct Neoplasms
"Common Bile Duct Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumor or cancer of the COMMON BILE DUCT including the AMPULLA OF VATER and the SPHINCTER OF ODDI.
| Descriptor ID |
D003138
|
| MeSH Number(s) |
C04.588.274.120.250.250 C06.130.120.120.280 C06.130.120.250.280 C06.130.320.120.280 C06.301.120.250.250
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Common Bile Duct Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Common Bile Duct Neoplasms".
This graph shows the total number of publications written about "Common Bile Duct Neoplasms" by people in this website by year, and whether "Common Bile Duct Neoplasms" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 4 | 0 | 4 |
| 2002 | 0 | 1 | 1 |
| 2003 | 3 | 0 | 3 |
| 2004 | 1 | 0 | 1 |
| 2005 | 2 | 0 | 2 |
| 2006 | 1 | 1 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 4 | 0 | 4 |
| 2009 | 1 | 0 | 1 |
| 2010 | 3 | 0 | 3 |
| 2012 | 2 | 0 | 2 |
| 2013 | 3 | 0 | 3 |
| 2015 | 2 | 0 | 2 |
| 2016 | 2 | 0 | 2 |
| 2017 | 5 | 0 | 5 |
| 2018 | 1 | 1 | 2 |
| 2019 | 3 | 0 | 3 |
| 2020 | 3 | 0 | 3 |
| 2023 | 3 | 0 | 3 |
| 2024 | 3 | 1 | 4 |
Below are the most recent publications written about "Common Bile Duct Neoplasms" by people in Profiles.
-
Oncological resection and perioperative outcomes of robotic, laparoscopic and open pancreatoduodenectomy for ampullary adenocarcinoma: a propensity score matched international multicenter cohort study. HPB (Oxford). 2025 Mar; 27(3):318-329.
-
The Five Periampullary Cancers, not Just Different Siblings but Different Families: An International Multicenter Cohort Study. Ann Surg Oncol. 2024 Sep; 31(9):6157-6169.
-
The road to tailored adjuvant chemotherapy for all four non-pancreatic periampullary cancers: An international multimethod cohort study. Br J Cancer. 2024 Jul; 131(1):117-125.
-
Incidence and risk factors for recurrence of ampullary adenomas after endoscopic papillectomy: Comparative analysis of familial adenomatous polyposis and sporadic ampullary adenomas in an international multicenter cohort. Dig Endosc. 2024 Jul; 36(7):834-842.
-
Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023 07; 21(7):753-782.
-
Invited Commentary: Adjuvant Chemotherapy Is Beneficial in Stage III Ampullary Adenocarcinoma. J Am Coll Surg. 2023 09 01; 237(3):512-514.
-
Early-Stage Ampullary Cancer: Is Local Excision an Effective Alternative to Radical Resection? J Am Coll Surg. 2023 07 01; 237(1):146-156.
-
Frequency and clinicopathologic associations of DNA mismatch repair protein deficiency in ampullary carcinoma: Routine testing is indicated. Cancer. 2020 11 01; 126(21):4788-4799.
-
Development and external validation of a prediction model for survival in patients with resected ampullary adenocarcinoma. Eur J Surg Oncol. 2020 09; 46(9):1717-1726.
-
Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study. Br J Surg. 2020 08; 107(9):1171-1182.